Skip to main content

Find Clinical Trials

Home
Conditions
Solid Tumors

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

582 public trials 81 recruiting studies

Refine in advanced search Browse all conditions

Solid Tumors trial results

Completed

Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma

NCT01438554

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +14 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Study of NGR-hTNF Administered at High Doses in Patient With Advanced or Metastatic Solid Tumour

NCT00878111

Conditions: Solid Tumors
Locations: Istituto Clinico Humanitas Rozzano, Milan, Italy

View Trial Details

Completed

Redosing With CP-870, 893 in Patients With Clinical Benefit After a Single Infusion From A Phase I, Open-Label, Dose-Escalation Study of CP-870,893 in Patients With Solid Tumors

NCT02157831

Conditions: Solid Tumors
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

AT13387 in Adults With Refractory Solid Tumors

NCT01246102

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors

NCT01259479

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +8 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors

NCT02439489

Conditions: Solid Tumors
Locations: Ospedale San Raffaele Milan, MI, Italy

View Trial Details

Completed

A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With Cancer

NCT00878449

Conditions: Solid Tumors
Locations: Site Reference ID/Investigator# 13323 Chicago, Illinois, United States

Site Reference ID/Investigator# 12841 Maywood, Illinois, United States

Site Reference ID/Investigator# 12303 Baltimore, Maryland, United States

Site Reference ID/Investigator# 12305 Boston, Massachusetts, United States

View Trial Details

Completed

Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors

NCT01978964

Conditions: Solid Tumors
Locations: Mary Crowley Cancer Research Centers Dallas, Texas, United States

View Trial Details

Completed

Phase 1 Study of ONT-10 in Patients With Solid Tumors

NCT01556789

Conditions: Solid Tumors
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

Mary Crowley Cancer Research Center Dallas, Texas, United States

Northwest Medical Specialties, PLLC Tacoma, Washington, United States

View Trial Details

Completed

A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols

NCT00884312

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Pinnacle Oncology Hematology Scottsdale, Arizona, United States

Tower Cancer Research Foundation Beverly Hills, California, United States

City of Hope National Medial Center Duarte, California, United States

University of California Medical Center San Francisco, California, United States

View all 23 locations

View Trial Details